La maladie de Parkinson au Canada (serveur d'exploration) - Curation (Ncbi)

Index « Keywords » - entrée « Alzheimer Disease (metabolism) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Alzheimer Disease (immunology) < Alzheimer Disease (metabolism) < Alzheimer Disease (nursing)  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 33.
[0-20] [0 - 20][0 - 33][20-32][20-40]
Ident.Authors (with country if any)Title
000112 (????) C. Schwab [Canada] ; A J Demaggio ; N. Ghoshal ; L I Binder ; J. Kuret ; P L McgeerCasein kinase 1 delta is associated with pathological accumulation of tau in several neurodegenerative diseases.
000131 (2000) A. Klegeris [Canada] ; P L McgeerR-(-)-Deprenyl inhibits monocytic THP-1 cell neurotoxicity independently of monoamine oxidase inhibition.
000343 (1992) J. Mclaurin [Canada] ; G. Hashim ; M A MoscarelloAn antibody specific for component 8 of myelin basic protein from normal brain reacts strongly with component 8 from multiple sclerosis brain.
000351 (1992) R F Peppard [Canada] ; W R Martin ; G D Carr ; E. Grochowski ; M. Schulzer ; M. Guttman ; P L Mcgeer ; A G Phillips ; J K Tsui ; D B CalneCerebral glucose metabolism in Parkinson's disease with and without dementia.
000368 (2002) Patrick L. Mcgeer [Canada] ; Edith G. McgeerInnate immunity, local inflammation, and degenerative disease.
000437 (2004) Hyman M. Schipper [Canada]Brain iron deposition and the free radical-mitochondrial theory of ageing.
000453 (2004) Gloria Lee [Canada] ; Reina BendayanFunctional expression and localization of P-glycoprotein in the central nervous system: relevance to the pathogenesis and treatment of neurological disorders.
000575 (2005) Thomas J. Montine [États-Unis] ; Ke Li ; Daniel P. Perl ; Douglas GalaskoLack of beta-methylamino-l-alanine in brain from controls, AD, or Chamorros with PDC.
000732 (1992) I. Aubert [Canada] ; D M Araujo ; D. Cécyre ; Y. Robitaille ; S. Gauthier ; R. QuirionComparative alterations of nicotinic and muscarinic binding sites in Alzheimer's and Parkinson's diseases.
000896 (2009) Sadayuki Hashioka ; Andis Klegeris ; Claudia Schwab ; Patrick L. McgeerInterferon-gamma-dependent cytotoxic activation of human astrocytes and astrocytoma cells.
000915 (2008) Patrick L. Mcgeer [Canada] ; Edith G. McgeerThe alpha-synuclein burden hypothesis of Parkinson disease and its relationship to Alzheimer disease.
000D24 (1990) R F Peppard [Canada] ; W R Martin ; C M Clark ; G D Carr ; P L Mcgeer ; D B CalneCortical glucose metabolism in Parkinson's and Alzheimer's disease.
000D25 (1990) E G Mcgeer [Canada] ; P L Mcgeer ; R. Harrop ; H. Akiyama ; H. KamoCorrelations of regional postmortem enzyme activities with premortem local glucose metabolic rates in Alzheimer's disease.
000D52 (1990) R. Quirion [Canada] ; I. Aubert ; Y. Robitaille ; S. Gauthier ; D M Araujo ; J G ChabotNeurochemical deficits in pathological brain aging: specificity and possible relevance for treatment strategies.
000E65 (1990) S J Kish [Canada] ; L M Distefano ; S. Dozic ; Y. Robitaille ; A. Rajput ; J H Deck ; O. Hornykiewicz[3H]vesamicol binding in human brain cholinergic deficiency disorders.
001220 (2012) David Westaway ; Jack H. JhamandasThe P’s and Q’s of cellular PrP-Aβ interactions
001237 (2012) Janelle Drouin-Ouellet [Canada] ; Francesca CicchettiInflammation and neurodegeneration: the story 'retolled'.
001260 (2013) Sungwon Han [Canada] ; Christopher Auger ; Zachary Castonguay ; Varun P. Appanna ; Sean C. Thomas ; Vasu D. AppannaThe unravelling of metabolic dysfunctions linked to metal-associated diseases by blue native polyacrylamide gel electrophoresis.
001375 (2013) Andrea Gold [Canada] ; Zorbey T. Turkalp ; David G. MunozEnteric alpha-synuclein expression is increased in Parkinson's disease but not Alzheimer's disease.
001386 (2013) Tiago A. Mestre [Canada] ; Mateusz Zurowski ; Susan H. Fox5-Hydroxytryptamine 2A receptor antagonists as potential treatment for psychiatric disorders.
001A94 (2015) Hyman M. Schipper [Canada] ; Wei SongA Heme Oxygenase-1 Transducer Model of Degenerative and Developmental Brain Disorders

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Ncbi/Curation
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i -k "Alzheimer Disease (metabolism)" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/KwdEn.i  \
                -Sk "Alzheimer Disease (metabolism)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Ncbi
   |étape=   Curation
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Alzheimer Disease (metabolism)
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022